MOLLI AGUILLARD: Open Payments
NPI 1205454899 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 29 payments from 10 companies in 2025. Trend: 2023 $359 · 2024 $511 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Evofem Biosciences, Inc. | 5 | $94 |
| Sage Therapeutics, LLC | 4 | $84 |
| Astellas Pharma US Inc | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Exeltis, USA Inc. | 4 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $51 |
| MILLICENT US INC | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Organon LLC | 1 | $10 |
Products named: Phexxi, ZURZUVAE, Veozah, MYFEMBREE, SLYND, EVENITY, ACCRUFER, FEMLYV.
Industry payments across LA — which companies pay providers there.
